Categories
Property

Remote Work Continues To Weigh On Office Recovery

Business Strategy & Outlook:   

The company’s strategy is to develop and own premier properties that maintain high occupancy rates and achieve premium rental rates through economic cycles in supply-constrained markets that have the strongest economic growth and investment characteristics for office real estate. Management has also outlined its policies on capital recycling to ensure continuous portfolio refreshment and value creation while maintaining a strong balance sheet and having adequate access to capital to take advantage of opportunistic situations. The company also welcomes management’s focus on ESG as it aligns its office portfolio to meet the sustainability requirements of its clients. 

The economic uncertainty emanating from pandemic recovery and the remote work dynamic has created a challenging environment for owners of office real estate. Employees are still hesitant in returning to the office as office utilization remains at approximately 45% of the pre-pandemic level. The national vacancy rate for office spaces was recorded at 17.5% in Q1 2022, which is roughly 500 basis points higher than pre-pandemic levels. The net absorption rate was marginally negative as of Q1 2022 and rental growth figures remain disappointing given the highly inflationary environment. Having said this, the company has seen an increasing number of companies requiring their employees to return to the office. In the long run, company believes that remote work and hybrid remote work solutions will gain increasing acceptance, but offices will continue to be the centerpiece of workplace strategy and will play an essential role in facilitating collaboration, harnessing innovation, and maintaining the company culture.

Financial Strengths:  

Boston Properties is in sound financial health. The company’s share of debt which also includes its share of unconsolidated joint venture debt was $12.9 billion as of the end of the fourth quarter in 2021, resulting in a debt/EBITDAre ratio of 7.7 times. The current debt/EBITDAre ratio is probably on the higher side and is slightly above the company’s long-term average. However, company thinks that the figure should return to the industry average over the next few years as fundamentals recover and EBITDA sees healthy growth. The weighted average interest rate on the company’s debt was 3.40% and the weighted average maturity period was 6.6 years. The maturity schedule of the company’s debt shows that the maturities are adequately spread. Company believes

 that the leverage used by the company to fund its capital structure is appropriate given the high-quality office portfolio. The fixed charge coverage ratio which is a ratio of EBITDAre divided by all fixed expenses (including interest expenses) was 2.8 times as of the end of 2021. As a real estate investment trust, Boston Properties is required to pay out at least 90% of its income as dividends to shareholders. The FAD payout ratio which is a ratio of dividends to funds available for distribution was reported at 92.1% for the year 2021. This shows that the company is generating sufficient cash to cover its fixed expenses and payout dividends

Bulls Say: 

  • Boston Properties owns premier properties in supply constrained cities which have favorable regional dynamics and strong growth prospects. Additionally, the life sciences portfolio of the company should benefit from the strong demand in the burgeoning sector.
  • The company’s high-quality office buildings with good amenities should benefit from the flight to quality trend. 
  • Boston Properties’ balance sheet strength, its access to low-cost capital, and its development expertise allow it to pursue lucrative large-scale development projects that generate value for shareholders.

Company Description:  

Boston Properties develops, owns, and manages Class A office properties that are mainly concentrated in six markets–Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, D.C. It owns over 200 properties consisting of approximately 53 million rentable square feet of space. The company has positioned itself to benefit from the burgeoning life sciences sector as it owns approximately 4.6 million square feet of life sciences space and has an additional 5 million square feet of future development potential.

(Source: Morningstar)

DISCLAIMER for General Advice: (This document is for general advice only).

This document is provided by Laverne Securities Pty Ltd T/as Laverne Investing. Laverne Securities Pty Ltd, CAR 001269781 of Laverne Capital Pty Ltd AFSL No. 482937.

The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require.  The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation, and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.

The material in this document has been obtained from sources believed to be true but neither Laverne and Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and, Laverne and Banyan Tree are not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

Laverne and Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Laverne and Banyan Tree do and seek to do business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.

Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Laverne and Banyan Tree, its associates, officers, directors, employees, and agents.  Except for any liability which cannot be excluded, Laverne and Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material.  Recipients of this document agree in advance that Laverne and Banyan Tree are not liable to recipients in any matters whatsoever otherwise; recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Laverne and Banyan Tree do not guarantee reliability and accuracy of the material contained in this document and are not liable for any unintentional errors in the document.

The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Laverne and Banyan Tree.

Categories
Technology Stocks

Marqeta offers impressive growth, but Its reliance on block Is a Concern

Business Strategy & Outlook:   

Marqeta has recently enjoyed rapid revenue and volume growth that has led to improving margins, though the company is still unprofitable. Marqeta’s operating cost structure is mostly fixed, so higher processing volume on debit and credit cards issued on its platform naturally leads to better margins for the firm, creating a road map for profitability as volume grows. The Marqeta card-issuing platform provides its customers with the infrastructure and application programming interfaces, or APIs, needed to build and rapidly deploy innovative card payment systems without preexisting payment expertise. The unique capabilities and flexibility of Marqeta’s platform has allowed it to find success with fintech and technology companies, with buy now pay later firms and Block being the most notable. Marqeta continues to benefit from the high organic growth its customer base provides, and the transition to digital payments as digital card issuance and tokenization are among its strengths, with major firms like Citi and JPMorgan using its digital issuance technology. 

That said, Marqeta has a genuine problem with customer concentration. More than 80% of Marqeta’s revenue comes from its two largest customers, with Block alone accounting for around 65% of net revenue. This creates serious risk for Marqeta as either a loss of this relationship or a material deterioration in contract terms could have serious repercussions on Marqeta’s business model. Marqeta’s current agreement with Block lasts until 2024, giving Marqeta some breathing room, but the firm’s reliance on Block will be an ongoing concern as it is the company’s largest source of risk. In a more positive light, Marqeta has announced deals to create debit cards for Bill.com and Goldman Sachs’ Marcus—major wins for the company. It is also moving forward with plans to expand its international business and move into credit card issuance. While these efforts are still in their early stages, these plans along with its recent contract wins provides Marqeta with a potential road map to continue its rapid growth and address its concentration issues.

Financial Strengths:  

Marqeta is in a very strong financial position, particularly after raising $1.2 billion in its IPO. Marqeta ended March 2022 with over $1.6 billion in cash and investment securities on its balance sheet. With no long-term debt outstanding, this provides the company with ample financial resources to invest back into its business, without the need to raise more capital. Additionally, Marqeta’s business requires little investment capital, even as it grows rapidly. The company is first and foremost a financial technology firm, and requires very little physical assets. Marqeta also collects interchange revenue from merchants before paying its customers their share, meaning the company has low net working capital requirements due to its high accounts payable. In fact, the company generated positive cashflow from operations in 2021 and used less than $50 million in 2022. This places Marqeta in the position of having substantial financial assets but little to no cash burn. While the company expects Marqeta to remain unprofitable for the immediate future, it also sees little risk of financial strain given the strength of its balance sheet.

Bulls Say: 

  • Marqeta’s platform and open APIs for card issuance continue to attract large and sophisticated firms like Goldman Sachs’ Marcus and Google to its platform, highlighting the strength of its offerings.
  • Marqeta’s existing customer base includes disruptive firms like Square and Klarna, which provides Marqeta with strong organic growth from its existing user base.
  • Marqeta’s cost structure is mostly fixed, allowing the company to naturally expand its margins as volume grows.

Company Description:  

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company’s open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

(Source: Morningstar)

DISCLAIMER for General Advice: (This document is for general advice only).

This document is provided by Laverne Securities Pty Ltd T/as Laverne Investing. Laverne Securities Pty Ltd, CAR 001269781 of Laverne Capital Pty Ltd AFSL No. 482937.

The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require.  The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation, and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.

The material in this document has been obtained from sources believed to be true but neither Laverne and Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and, Laverne and Banyan Tree are not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

Laverne and Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Laverne and Banyan Tree do and seek to do business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.

Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Laverne and Banyan Tree, its associates, officers, directors, employees, and agents.  Except for any liability which cannot be excluded, Laverne and Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material.  Recipients of this document agree in advance that Laverne and Banyan Tree are not liable to recipients in any matters whatsoever otherwise; recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Laverne and Banyan Tree do not guarantee reliability and accuracy of the material contained in this document and are not liable for any unintentional errors in the document.

The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Laverne and Banyan Tree.

Categories
Technology Stocks

As Shares Fall Amid Fiscal Fourth-Quarter Struggles, Canopy Pushes Back EBITDA Profitability to 2024

Business Strategy & Outlook

Canopy Growth grows and sells cannabis products primarily in Canada, which accounts for roughly 50% of sales. Non-THC product sales account for about 30%. Canadian recreational accounts for roughly 60% of cannabis sales. Although the medical market to shrink as consumers turn to the recreational market, and more than 10% average annual growth for the entire Canadian market through 2030, driven by the conversion of black-market consumers into the legal market and new cannabis consumers.

Canopy also exports medical cannabis globally. The global market looks lucrative, given higher prices and growing acceptance of cannabis’ medical benefits. Exporters must pass strict regulations to enter markets, protecting early entrants like Canopy. Partially offsetting the global markets’ potential for Canadian producers are threats of future production from countries with cheaper labor— the single largest cost. However, many Canadian companies have pulled back expansion plans given ongoing cash burn. As per forecast around 15% average annual growth through 2030.

 Canopy has a standing deal to acquire Acreage Holdings, a U.S. multistate operator, immediately upon federal legalization. The Canopy paid a good price and acquired an attractive option for an accelerated entry into the U.S. Canopy also owns 27% of U.S. multistate operator Terraced on a fully diluted basis. These U.S. assets look far more attractive than the continued challenges in the Canadian market. The U.S. market is murky, with some states legalizing recreational or medical cannabis while it remains illegal federally. The federal law will be changed to recognize states’ choices on legality within their borders, which would trigger Canopy’s deals. Based on state-by-state analysis, the nearly 20% average annual growth for the U.S. recreational market and nearly 10% for the medical market through 2030. Constellation Brands owns 38.6% of Canopy with additional securities that could push ownership to 55.8%. The investment as supportive of developing branded cannabis consumer products while also providing a funding backstop and foothold into the U.S. non-THC market.

Financial Strengths

On one hand, Canopy Growth’s debt remains relatively low. At the end of the fourth quarter of fiscal 2022, the company had about CAD 1.5 billion of debt compared with a market capitalization of roughly CAD 2.5 billion. On the other hand, the company continues to burn cash, which pressures its financial health. However, management has been focused on reducing capital spending and rightsizing its overhead, minimizing the need for further outside capital. The company will generate positive adjusted EBITDA in fiscal 2025 and positive free cash flow in fiscal 2026. The company’s target of positive adjusted EBITDA in fiscal 2024 looks possible in the latter half of the year, but no one had anticipate losses for the sum of the year. In the latter 10-year forecast, we think the company will generate enough positive free cash flow to reduce its debt. Benefiting its financial health, Canopy has generally relied on equity to fund acquisitions and expansion. The company’s first major debt raise occurred as recently as its first quarter of fiscal 2019. The company will continue to rely on equity to fund capital needs, which is typical for growth companies such as Canopy to help alleviate potential pressure on its financial health. Constellation Brands as a major strategic investor also adds a stabilizing presence to Canopy’s financial health.

Bulls Say

  • Canopy Growth’s deal to acquire Acreage Holdings immediately upon U.S. federal legalization provides exposure to the largest potential cannabis market in the world.
  • Canopy Growth’s ownership of 27% of Terrascend gives it further optionality for the U.S. THC market.
  • The investment by Constellation Brands and partnerships with Martha Stewart and Snoop Dogg provide potential expansion opportunities into infused products and topicals. If successful, Constellation Brands may increase its ownership or try to acquire Canopy.

Company Description

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and Craft Grow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

(Source: Morningstar)

DISCLAIMER for General Advice: (This document is for general advice only).

This document is provided by Laverne Securities Pty Ltd T/as Laverne Investing. Laverne Securities Pty Ltd, CAR 001269781 of Laverne Capital Pty Ltd AFSL No. 482937.

The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require.  The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation, and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.

The material in this document has been obtained from sources believed to be true but neither Laverne and Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and, Laverne and Banyan Tree are not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

Laverne and Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Laverne and Banyan Tree do and seek to do business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.

Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Laverne and Banyan Tree, its associates, officers, directors, employees, and agents.  Except for any liability which cannot be excluded, Laverne and Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material.  Recipients of this document agree in advance that Laverne and Banyan Tree are not liable to recipients in any matters whatsoever otherwise; recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Laverne and Banyan Tree do not guarantee reliability and accuracy of the material contained in this document and are not liable for any unintentional errors in the document.

The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Laverne and Banyan Tree.

Categories
Daily Report Financial Markets

Japan Market Outlook – 31 May 2022

Categories
Daily Report Financial Markets

Australian Market Outlook – 31 May 2022

Categories
Analyst videos Brokers call Brokers Call Expert Insights Fund Manager Interviews Philosophy Stock Talks Technical Picks VidCons Videos

Brokers Call – 31 May 2022

Categories
Daily Report

Morning Report Global Markets Update – 31 May 2022

Categories
Daily Report Financial Markets

USA Market Outlook – 31 May 2022

Categories
Daily Report Financial Markets

Japan Market Outlook – 30 May 2022

Categories
Daily Report

Morning Report Global Markets Update – 30 May 2022